Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07611786 · ClinicalTrials.gov registry record
Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
A clinical trial, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- 40
- Enrollment target
NCT07611786 is a clinical trial that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants.
The verdict
NCT07611786 has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.
Interventions
- OTHER exposure to healthcare transition protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07 |
| Est. Completion | 2029-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07611786
The ClinicalTrials.gov registry entry for NCT07611786 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which exposure to healthcare transition protocol is the first listed.
NCT07611786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07611786 about?
NCT07611786 is a clinical study titled "Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia". The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, d...
What is the current status of trial NCT07611786?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-07. Estimated completion is 2029-07.
What interventions are being tested in trial NCT07611786?
The interventions under investigation include: exposure to healthcare transition protocol (OTHER).
Who is sponsoring clinical trial NCT07611786?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.